163 related articles for article (PubMed ID: 31796840)
1. Absence of severe neonatal ABO hemolytic disease at Intermountain Healthcare. Why?
Baer VL; Hulse W; Bahr TM; Ilstrup SJ; Christensen RD
J Perinatol; 2020 Feb; 40(2):352-353. PubMed ID: 31796840
[No Abstract] [Full Text] [Related]
2. ABO hemolytic disease of the fetus and newborn: thirteen years of data after implementing a universal bilirubin screening and management program.
Christensen RD; Baer VL; MacQueen BC; O'Brien EA; Ilstrup SJ
J Perinatol; 2018 May; 38(5):517-525. PubMed ID: 29410540
[TBL] [Abstract][Full Text] [Related]
3. The value of transcutaneous method of bilirubin measurement in newborn population with the risk of ABO hemolytic disease.
Stoniene D; Buinauskiene J; Markūniene E
Medicina (Kaunas); 2009; 45(10):792-7. PubMed ID: 19996666
[TBL] [Abstract][Full Text] [Related]
4. Prediction of ABO hemolytic disease of the newborn using pre- and perinatal quantification of maternal anti-A/anti-B IgG titer.
Krog GR; Donneborg ML; Hansen BM; Lorenzen H; Clausen FB; Jensen KV; Kjærbye-Thygesen A; Albertsen P; Ebbesen F; Bergholt T; Smed MK; Dziegiel MH
Pediatr Res; 2021 Jul; 90(1):74-81. PubMed ID: 33173174
[TBL] [Abstract][Full Text] [Related]
5. ABO hemolytic disease of newborn : Does newborn's blood group a risk factor?
Bel Hadj I; Boukhris R; Khalsi F; Namouchi M; Bougmiza I; Tinsa F; Hamouda S; Boussetta K
Tunis Med; 2019 Mar; 97(3):455-460. PubMed ID: 31729720
[TBL] [Abstract][Full Text] [Related]
6. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis].
Cortey A; Elzaabi M; Waegemans T; Roch B; Aujard Y
Arch Pediatr; 2014 Sep; 21(9):976-83. PubMed ID: 25125032
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of universal hyperbilirubinemia screening on newborn health: a systematic review protocol.
Khurshid F; Medves J
JBI Database System Rev Implement Rep; 2018 Feb; 16(2):287-290. PubMed ID: 29419612
[TBL] [Abstract][Full Text] [Related]
9. [Meta analysis of the effect of immunoglobulin infusion on neonatal isoimmune hemolytic disease caused by blood group incompatibility].
Li ZH; Wang J; Chen C
Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):656-60. PubMed ID: 21092522
[TBL] [Abstract][Full Text] [Related]
10. [Hemolytic disease of the newborn due to incompatibility of the ABO system. Bilirubin encephalopathy].
Malaguzzi Valeri O; Sbraccia C; Carapella De Luca E; Di Piero G; Mencarini L; Natoli G; Natoli V; Valeri OM
Minerva Pediatr; 1967 Sep; 19(36):1678-86. PubMed ID: 5629556
[No Abstract] [Full Text] [Related]
11. Incidence and etiology of neonatal hyperbilirubinemia.
Sarici SU
J Trop Pediatr; 2010 Apr; 56(2):128-9. PubMed ID: 19502601
[No Abstract] [Full Text] [Related]
12. Indication of Mild Hemolytic Reaction Among Preterm Infants With ABO Incompatibility.
Yogev-Lifshitz M; Leibovitch L; Schushan-Eisen I; Taran C; Strauss T; Maayan-Metzger A
Pediatr Blood Cancer; 2016 Jun; 63(6):1050-3. PubMed ID: 26841084
[TBL] [Abstract][Full Text] [Related]
13. Phototherapy in ABO hemolytic disease of the newborn infant.
Kaplan E; Herz F; Scheye E; Robinson LD
J Pediatr; 1971 Dec; 79(6):911-4. PubMed ID: 5132303
[No Abstract] [Full Text] [Related]
14. Revisiting ABO incompatibility as a risk factor for significant neonatal hyperbilirubinemia.
Khurana R; Batra P; Faridi M; Khan N
Trop Doct; 2019 Jul; 49(3):201-204. PubMed ID: 30943888
[TBL] [Abstract][Full Text] [Related]
15. [Value of immunologic tests in the hemolytic disease of the newborn in ABO incompatibility].
Kourteva B; Doitchinova N; Chinkov D
Nouv Rev Fr Hematol; 1968; 8(6):892-4. PubMed ID: 4236876
[No Abstract] [Full Text] [Related]
16. Causes of hemolysis in neonates with extreme hyperbilirubinemia.
Christensen RD; Nussenzveig RH; Yaish HM; Henry E; Eggert LD; Agarwal AM
J Perinatol; 2014 Aug; 34(8):616-9. PubMed ID: 24762414
[TBL] [Abstract][Full Text] [Related]
17. Indirect neonatal hyperbilirubinemia in hospitalized neonates on the Thai-Myanmar border: a review of neonatal medical records from 2009 to 2014.
Thielemans L; Trip-Hoving M; Landier J; Turner C; Prins TJ; Wouda EMN; Hanboonkunupakarn B; Po C; Beau C; Mu M; Hannay T; Nosten F; Van Overmeire B; McGready R; Carrara VI
BMC Pediatr; 2018 Jun; 18(1):190. PubMed ID: 29895274
[TBL] [Abstract][Full Text] [Related]
18. Severe Neonatal Hyperbilirubinemia Decreased after the 2007 Canadian Guidelines.
Sgro M; Kandasamy S; Shah V; Ofner M; Campbell D
J Pediatr; 2016 Apr; 171():43-7. PubMed ID: 26852177
[TBL] [Abstract][Full Text] [Related]
19. Is Cord Blood Bilirubin Level a Reliable Predictor for Developing Significant Hyperbilirubinemia?
Aktas S; Dogan C; Okmen ZH; Gulec SG
Am J Perinatol; 2019 Feb; 36(3):317-321. PubMed ID: 30081396
[TBL] [Abstract][Full Text] [Related]
20. Risk of neonatal hyperbilirubinemia in babies born to 'O' positive mothers: a prospective cohort study.
Kalakheti BK; Singh R; Bhatta NK; Karki A; Baral N
Kathmandu Univ Med J (KUMJ); 2009; 7(25):11-5. PubMed ID: 19483446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]